
Cancer therapies are the cornerstone of personalized medicine, a form of medicine that uses information about a person’s DNA profile to treat cancer. At present, Oncologists act on limited information to try and match one of these anti-cancer drugs to an individual’s condition, therefore the probability of getting the correct match is very low. The presence or absence of certain mutations can predict who may benefit from certain drugs and who is not likely to respond.